Evidence map›Paper›PMID 41706382›Full record

ArticleDiscover oncology2026

Integrating features of radiomics and CNN models for early skin cancer detection based on watershed segmentation.

Abdullah Shoaib Alshmrani, Fahad M Alotaibi, Ahmed S Alfakeeh

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdullah Shoaib AlshmraniDepartment of Information Systems, Faculty of Computing and Information Technology (FCIT), King Abdulaziz University, Jeddah, 21589, Saudi Arabia. AALSHMRANI0113@stu.kau.edu.sa.
Fahad M AlotaibiDepartment of Information Systems, Faculty of Computing and Information Technology (FCIT), King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Ahmed S AlfakeehDepartment of Information Systems, Faculty of Computing and Information Technology (FCIT), King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer is among the most aggressive and prevalent forms of cancer worldwide, with melanoma posing a high risk of metastasis and mortality when not detected early. Manual diagnosis by dermatologists, while effective, faces challenges such as subjectivity, variability, and limited accessibility in underserved regions. To address these limitations, this study proposes a robust computer-aided diagnostic system for early detection of skin cancer using a hybrid feature extraction approach and machine learning. In this study, several methodologies were developed for the automated classification of dermoscopic images, with a primary focus on a hybrid diagnostic model combining radiomic and deep learning features. Specifically, a Random Forest (RF) classifier was trained on fused features extracted from radiomic algorithms and deep convolutional layers of CNN. The proposed MobileNetV2 + radiomics + RF model achieved outstanding performance, with an average AUC of 85.09%, accuracy of 94.7%, sensitivity of 84.53% and specificity exceeding 99.2%. It exhibited particularly strong classification capabilities for high-risk lesions such as melanoma (AUC of 94.4%) and nevi (AUC of 98.2%), while maintaining robust performance across other lesion types. The integration of radiomic and CNN-based features through an RF classifier offers a highly effective approach for early skin cancer detection, with significant implications for clinical practice.

Indexed as

ANNCNNCombining featuresRadiomicRFSkin cancerWatershed

Identifiers

PMID41706382
PMCPMC13022138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.